|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | |
| A61K 39/00 |
| (11) | Number of the document | 1677875 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04769011.0 |
| Date of filing the European patent application | 2004-10-22 | |
| (97) | Date of publication of the European application | 2006-07-12 |
| (45) | Date of publication and mention of the grant of the patent | 2010-06-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2004/004502 |
| Date | 2004-10-22 |
| (87) | Number | WO 2005/042102 |
| Date | 2005-05-12 |
| (30) | Number | Date | Country code |
| 0324656 | 2003-10-22 | GB |
| (72) |
BURGESS, Nicola Anne, Celltech R & D Limited, GB
|
| (73) |
UCB Pharma, S.A.,
Allée de La Recherche 60, 1070 Brussels,
BE
|
| (54) | A PROTEIN INVOLVED IN OVARIAN CANCER |
| A PROTEIN INVOLVED IN OVARIAN CANCER |